Drug Type Monoclonal antibody |
Synonyms TGC-9 |
Target |
Action inhibitors |
Mechanism IBSP inhibitors(integrin binding sialoprotein inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | Germany | 01 May 2009 | |
Breast Cancer | Preclinical | Germany | 01 May 2009 | |
Neoplasms | Discovery | Germany | - |